Texas Oncology-El Paso Cancer Treatment Center Grandview — El Paso, Texas

Texas Oncology-El Paso Cancer Treatment Center Grandview is a clinical research site located in El Paso, Texas, United States 79902.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-El Paso Cancer Treatment Center Grandview has participated in 4 clinical trials.

Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Sponsors: Pfizer, Hoffmann-La Roche, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-El Paso Cancer Treatment Center Grandview?

Texas Oncology-El Paso Cancer Treatment Center Grandview has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-El Paso Cancer Treatment Center Grandview conducted?

Texas Oncology-El Paso Cancer Treatment Center Grandview has 4 clinical trials on record. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Is Texas Oncology-El Paso Cancer Treatment Center Grandview accredited by Crixeo Health?

Yes — Texas Oncology-El Paso Cancer Treatment Center Grandview holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-El Paso Cancer Treatment Center Grandview?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.